Simplify Propel Opportunities ETF (SURI) is an ETF managed by Independent / Boutique. Its largest position is PLAINS GP HOLDINGS LP (PAGP), representing 44.55% of fund assets.
Simplify Propel Opportunities ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SURI
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 27, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
PLAINS GP HOLDINGS LP
|
44.55% | $30,892,900.80 | 1,272,360 |
|
-
ACHIEVE LIFE SCIENCES, INC.
|
5.02% | $3,482,465.28 | 1,184,512 |
|
-
Phathom Pharmaceuticals, Inc.
|
4.20% | $2,915,108.46 | 262,386 |
|
-
DELCATH SYSTEMS, INC.
|
3.49% | $2,423,249.28 | 261,126 |
|
-
ABEONA THERAPEUTICS INC.
|
3.23% | $2,241,532.16 | 500,342 |
|
-
Celldex Therapeutics, Inc.
|
3.16% | $2,188,489.68 | 68,994 |
|
-
Milestone Pharmaceuticals Inc.
|
2.58% | $1,792,621.95 | 1,506,405 |
|
-
Oculis Holding AG
|
2.56% | $1,772,675.53 | 66,667 |
|
-
LeonaBio, Inc.
|
2.21% | $1,534,588.12 | 149,279 |
|
-
CORCEPT THERAPEUTICS INC
|
2.19% | $1,522,226.53 | 37,763 |
|
-
Kyverna Therapeutics, Inc.
|
2.15% | $1,493,904.78 | 173,106 |
|
-
Inventiva S.A.
|
1.82% | $1,264,972.65 | 227,923 |
|
-
Viridian Therapeutics, Inc.\DE
|
1.59% | $1,099,878.36 | 56,231 |
|
-
Aquestive Therapeutics, Inc.
|
1.40% | $972,257.85 | 234,279 |
|
-
Vor Biopharma Inc.
|
1.38% | $954,618.40 | 53,510 |
|
-
Orchestra BioMed Holdings, Inc.
|
1.34% | $932,394.75 | 219,387 |
|
-
ZEVRA THERAPEUTICS, INC.
|
1.29% | $897,012.72 | 96,246 |
|
-
COMPASS Pathways plc
|
1.27% | $879,557.56 | 159,052 |
|
-
Trevi Therapeutics, Inc.
|
1.13% | $780,365.16 | 65,412 |
|
-
OCULAR THERAPEUTIX, INC
|
1.10% | $762,300.00 | 90,000 |
|
-
SAB Biotherapeutics, Inc.
|
1.03% | $717,090.90 | 187,230 |
|
-
Upstream Bio, Inc.
|
1.01% | $700,137.00 | 77,793 |
|
-
EyePoint, Inc.
|
0.99% | $689,950.14 | 53,526 |
|
-
4D Molecular Therapeutics, Inc.
|
0.95% | $655,703.30 | 70,430 |
|
-
PALISADE BIO, INC.
|
0.88% | $612,500.00 | 350,000 |
|
-
Zealand Pharma A/S/ADR
|
0.82% | $568,782.90 | 12,330 |
|
-
Kalaris Therapeutics, Inc.
|
0.73% | $504,448.02 | 87,426 |
|
-
IMMUNIC, INC.
|
0.70% | $487,214.52 | 438,932 |
|
-
Coherus Oncology, Inc.
|
0.62% | $427,806.60 | 253,140 |
|
-
CONTRA AKERO THERAPEUT
|
0.62% | $426,634.37 | 145,609 |
|
-
Corvus Pharmaceuticals, Inc.
|
0.43% | $296,140.46 | 20,242 |
|
-
Ovid Therapeutics Inc.
|
0.42% | $290,404.86 | 130,813 |
|
-
Artiva Biotherapeutics, Inc.
|
0.22% | $149,601.20 | 23,230 |
|
-
Connect Biopharma Holdings Ltd
|
0.20% | $139,842.50 | 53,375 |
|
-
CONTRA CHINOOK THERAPE
|
0.00% | $2,500.00 | 25,000 |
|
-
EIGER BIOPHARMACEUTICALS INC
|
0.00% | $900.00 | 90,000 |
|
-
MILESTONE PHARMACE WTS
|
0.00% | $1.84 | 1,842,974 |
|
-
MILESTONE PHARMACE WTS
|
0.00% | $1.84 | 1,842,974 |
|
-
ACHIEVE LIFE SCIENCE INC
|
0.00% | $0.97 | 966,667 |
|
-
JASPER THERAPEUTIC WTS
|
0.00% | $0.61 | 609,053 |
|
-
WTS - TENAYA THERAPEUTICS
|
0.00% | $0.56 | 560,000 |
|
-
QUOIN PHARMACEUTIC WTS
|
0.00% | $0.03 | 34,895 |
|
-
QUOIN PHARMACEUTIC WTS
|
0.00% | $0.03 | 34,895 |
|
-
QUOIN PHARMACEUTIC WTS
|
0.00% | $0.03 | 34,895 |
|
-
QUOIN PHARMACEUTIC WTS
|
0.00% | $0.03 | 34,895 |
|
-
MORGAN STANLEY
|
-91.06% | -$63,152,370.00 | -63,152,370 |
Advertisement (320x50)